From Academia to Industry: WBBA Event

The Washington Biotechnology & Biomedical Association is organizing an event February 24 on how scientists can make the career transition from academia to industry. Mike Gallatin of Calistoga Pharmaceuticals, Jonathan Drachman of Seattle Genetics, and Kenneth Ferguson of Imvaxyn will speak on a panel moderated by Ulrich Mueller of the Fred Hutchinson Cancer Research Center. For more information, click here.